Patent details

EP3426254 Title: USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS

Basic Information

Publication number:
EP3426254
PCT Application Number:
IL2017050301
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP177626488
PCT Publication Number:
WO2017154001
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BRAF INHIBITORS FOR TREATING CUTANEOUS REACTIONS
French Title of Invention:
UTILISATION D'INHIBITEURS DE BRAF POUR LE TRAITEMENT DE RÉACTIONS CUTANÉES
German Title of Invention:
VERWENDUNG VON BRAF-HEMMERN ZUR BEHANDLUNG VON HAUTREAKTIONEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
07/06/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
12/06/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
07/06/2023
Unitary Effect Registration Date:
12/06/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
09/03/2017
Grant date:
07/06/2023
EP Publication Date:
16/01/2019
PCT Publication Date:
14/09/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2023
EP B1 Publication Date:
07/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/03/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2023
 
 

Name:
Lutris Pharma Ltd.
Address:
27 Habarzel St., 6971039 Tel Aviv, Israel (IL)

Inventor

Name:
SHELACH, Noa
Address:
Israel (IL)

Priority

Priority Number:
201662306147 P
Priority Date:
10/03/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/52; A61K 31/506; A61K 31/517; A61K 31/4375; A61P 17/00; A61K 31/167; A61K 31/44; A61K 31/4439; A61K 31/519; A61K 31/404;

Publication

European Patent Bulletin

1

Issue number:
202323
Publication date:
07/06/2023
Description:
Grant (B1)

2

Issue number:
202328
Publication date:
12/07/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202328
Publication date:
12/07/2023
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages